European Society for Paediatric Haematology and Immunoloy Abstracts

QUALITY OF LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-10 YEARS EARLIER: IDM/HDM AND LATE EFFECTS? 123

Three courses of IDM, 500 mg/m2 at three week intervals, were given to 126 children, and three courses of HDM, 2-6 g/m2, in 6 high risk children, as part of sanctuary treatment following induction therapy of a Norwegian treatment protocol during the period 1975-1980. No prophylactic irradiation was used.

A follow-up study of 93 (70%) survivors of this protocol and 5 of an other 21 cases of ALL in childhood diagnosed during the same 6-year-period, was performed.

A questionnaire of 10 pages with medical and psychosocial questions was used, with a family control in each case.

Forms were received in a total of 94 (96%) of the 98 surviving patients with leukemia, and on corresponding controls.

There was no significant difference between the 2 groups with respect to physical and mental health.

Author information

Affiliations

Authors

Additional information

The research work was done in all departments of Pediatrics in Norway.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Moe, P., Glomstein, A., Madsen, B. et al. QUALITY OF LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-10 YEARS EARLIER: IDM/HDM AND LATE EFFECTS? 123. Pediatr Res 41, 769 (1997). https://doi.org/10.1203/00006450-199705000-00142

Download citation